Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Persoonlijk profiel
Expertise gerelateerd aan duurzame ontwikkelingsdoelstellingen van de VN
In 2015 stemden de VN-lidstaten in met 17 wereldwijde duurzame ontwikkelingsdoelstellingen (Sustainable Development Goals, SDG's) om armoede te beëindigen, de planeet te beschermen en voor iedereen welvaart te garanderen. Het werk van deze persoon draagt bij aan de volgende duurzame ontwikkelingsdoelstelling(en):
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Dick de Zeeuw actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
-
Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double-blind, placebo-controlled, Phase I trial
Bornstein, S. R., de Zeeuw, D., Heerspink, H. J. L., Schulze, F., Cronin, L., Wenz, A., Tuttle, K. R., Hadjadj, S. & Rossing, P., jun.-2024, In: Diabetes, Obesity and Metabolism. 26, 6, blz. 2128-2138 11 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand1 Citaat (Scopus)10 Downloads (Pure) -
Methods Article for a Study Protocol: Study Design and Baseline Characteristics for Aldosterone Synthase Inhibition in Chronic Kidney Disease
Tuttle, K. R., Rossing, P., Hauske, S. J., Cronin, L., Hussain, J., de Zeeuw, D. & Heerspink, H. J. L., apr.-2024, In: American Journal of Nephrology. 55, 2, blz. 262–272 10 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand1 Citaat (Scopus)38 Downloads (Pure) -
Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering
Charytan, D. M., Mahaffey, K. W., Jardine, M. J., Cannon, C. P., Neal, B., Lambers Heerspink, H. J., Agarwal, R., Bakris, G. L., De Zeeuw, D., Levin, A., Pollock, C., Zhang, H., Zinman, B., Rosenthal, N., Perkovic, V., Di Tanna, G. L., Yu, J., Rogers, K., Arnott, C. & Wheeler, D. C., 2023, In: BMJ Open Diabetes Research and Care. 11, 3, 8 blz., e003270.Onderzoeksoutput › Academic › peer review
Open AccessBestand3 Citaten (Scopus)25 Downloads (Pure) -
Diuretic medication and change in fluid retention biomarkers during treatment with the endothelin receptor antagonist atrasentan
Smeijer, J. D., Kohan, D. E., de Zeeuw, D. & Heerspink, H. J. L., aug.-2023, In: Diabetes, Obesity and Metabolism. 25, 8, blz. 2419-2422 4 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand28 Downloads (Pure) -
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
ASi in CKD group, Tuttle, K. R., Hauske, S. J., Canziani, M. E., Caramori, M. L., Cherney, D., Cronin, L., Heerspink, H. J. L., Hugo, C., Nangaku, M., Rotter, R. C., Silva, A., Shah, S. V., Sun, Z., Urbach, D., de Zeeuw, D. & Rossing, P., 27-jan.-2023, In: The Lancet. 403, 10424, blz. 379-390 12 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand25 Citaten (Scopus)29 Downloads (Pure)
Datasets
-
Supplementary Material for: A Prospective Cohort Study in Patients with Type 2 Diabetes Mellitus for Validation of Biomarkers (PROVALID) – Study Design and Baseline Characteristics
Eder, S. (Creator), Leierer, J. (Creator), Kerschbaum, J. (Creator), Rosivall, L. (Creator), Wiecek, A. (Creator), De Zeeuw, D. (Creator), Mark, P. B. (Creator), Heinze, G. (Creator), Rossing, P. (Creator), Lambers Heerspink, H. (Creator) & Mayer, G. (Creator), figshare, 21-feb.-2018
DOI: 10.6084/m9.figshare.5909164, https://figshare.com/articles/Supplementary_Material_for_A_Prospective_Cohort_Study_in_Patients_with_Type_2_Diabetes_Mellitus_for_Validation_of_Biomarkers_PROVALID_Study_Design_and_Baseline_Characteristics/5909164
Dataset
-
Supplementary Material for: The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics
Jardine, M. J. (Creator), Mahaffey, K. W. (Creator), Neal, B. (Creator), Agarwal, R. (Creator), Bakris, G. L. (Creator), Brenner, B. M. (Creator), Bull, S. (Creator), Cannon, C. P. (Creator), Charytan, D. M. (Creator), De Zeeuw, D. (Creator), Edwards, R. (Creator), Greene, T. (Creator), Lambers Heerspink, H. (Contributor), Levin, A. (Creator), Pollock, C. (Creator), Wheeler, D. C. (Creator), Xie, J. (Creator), Zhang, H. (Creator), Zinman, B. (Creator), Desai, M. (Creator) & Perkovic, V. (Creator), Karger Publishers, 13-dec.-2017
DOI: 10.6084/m9.figshare.5696959, https://karger.figshare.com/articles/Supplementary_Material_for_The_Canagliflozin_and_Renal_Endpoints_in_Diabetes_with_Established_Nephropathy_Clinical_Evaluation_CREDENCE_Study_Rationale_Design_and_Baseline_Characteristics/5696959
Dataset
-
Supplementary Material for: Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes and Stage 3 Nephropathy
Yamout, H. (Creator), Perkovic, V. (Creator), Davies, M. (Creator), Woo, V. (Creator), De Zeeuw, D. (Creator), Mayer, C. (Creator), Vijapurkar, U. (Creator), Kline, I. (Creator), Usiskin, K. (Creator), Meininger, G. (Creator) & Bakris, G. (Contributor), Karger Publishers, 17-jul.-2014
DOI: 10.6084/m9.figshare.5126725, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Efficacy_and_Safety_of_Canagliflozin_in_Patients_with_Type_2_Diabetes_and_Stage_3_Nephropathy/5126725
Dataset
-
Additional file 1 of Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
Lienczewski, C. (Contributor), Karihaloo, A. (Contributor), Kretzler, M. (Contributor), Dutius Andersson, A.-M. (Contributor), Pontrelli, P. (Contributor), Gesualdo, L. (Contributor), Sharma, K. (Contributor), Welberry Smith, M. (Contributor), Gooding, K. M. (Contributor), Shore, A. C. (Contributor), Ibberson, M. (Contributor), Lambers Heerspink, H. (Contributor), Gomez, M. F. (Contributor), Gilchrist, M. (Contributor), Nuutila, P. (Contributor), Teh, I. (Contributor), Mansfield, M. (Contributor), Papale, M. (Contributor), Banks, R. E. (Contributor), Bailey, J. (Contributor), Andress, D. (Contributor), Koivuviita, N. (Contributor), Sourbron, S. (Contributor), Tobin, K. (Contributor), Metsärinne, K. (Contributor), Zetterqvist, A. (Contributor), Garcia Hernandez, A. (Contributor), De Zeeuw, D. (Contributor), Ball, C. (Contributor), Grenier, N. (Contributor), Saunavaara, V. (Contributor), Maziarz, M. (Contributor), Gilmour, P. S. (Contributor), Shelley, D. (Contributor) & Puppala, S. (Contributor), University of Groningen, 29-jun.-2020
DOI: 10.6084/m9.figshare.12586625.v1
Dataset
-
Additional file 2 of Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
Dutius Andersson, A.-M. (Contributor), Garcia Hernandez, A. (Contributor), Tobin, K. (Contributor), Ball, C. (Contributor), Saunavaara, V. (Contributor), Teh, I. (Contributor), Banks, R. E. (Contributor), Sharma, K. (Contributor), Lienczewski, C. (Contributor), Koivuviita, N. (Contributor), Metsärinne, K. (Contributor), De Zeeuw, D. (Contributor), Karihaloo, A. (Contributor), Mansfield, M. (Contributor), Lambers Heerspink, H. (Contributor), Maziarz, M. (Contributor), Gesualdo, L. (Contributor), Pontrelli, P. (Contributor), Bailey, J. (Contributor), Papale, M. (Contributor), Nuutila, P. (Contributor), Gomez, M. F. (Contributor), Ibberson, M. (Contributor), Gooding, K. M. (Contributor), Sourbron, S. (Contributor), Shelley, D. (Contributor), Grenier, N. (Contributor), Shore, A. C. (Contributor), Zetterqvist, A. (Contributor), Welberry Smith, M. (Contributor), Gilchrist, M. (Contributor), Kretzler, M. (Contributor), Gilmour, P. S. (Contributor), Puppala, S. (Contributor) & Andress, D. (Contributor), University of Groningen, 29-jun.-2020
DOI: 10.6084/m9.figshare.12586628.v1
Dataset